Misoprostol Vaginal Insert (MVI) 100-200 mcg efficacy and safety for labor induction evaluated in Phase III trial
Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor
Abstract
Misoprostol Vaginal Insert (MVI) at 100, 150, and 200 mcg doses was evaluated for cervical ripening and labor induction efficacy and safety in a Phase III trial.